When a Dosing Error Can Be Fatal.
Protecting medical oncologists, hematology-oncology groups, and cancer-care practices
Oncology practices treat the sickest patients with some of the most dangerous drugs in medicine, and that combination puts medical malpractice at the center of the risk. Chemotherapy agents have a narrow therapeutic index — the gap between a treating dose and a lethal one is small — so a dosing, compounding, or administration error can kill a patient, and a missed or delayed diagnosis lets a curable cancer become terminal. Because so many claims involve a patient who dies, oncology carries some of the highest claim severity in all of medicine. A cancer practice needs coverage built around treatment-error and diagnostic malpractice, drug-administration exposure, and the clinical-trial and billing risks unique to the field. This is a specialized corner of healthcare insurance built for how oncologists actually get sued.
Properly structured coverage protects the practice, its oncologists, and its patients.
The Oncologist's Signature Exposures
Medical malpractice is the core, and it is unusually severe. Chemotherapy and immunotherapy errors — a tenfold dosing mistake, a compounding or infusion error, the wrong regimen, or extravasation that causes tissue necrosis — can be fatal, and because the drugs are so toxic there is little margin to recover from a mistake. Running alongside treatment error is diagnostic liability: a missed or delayed cancer diagnosis or incorrect staging that allows a curable disease to spread. Informed-consent disputes over prognosis, risks, and options are constant in a field where outcomes are often poor, and off-label regimens, clinical-trial enrollment, and coordination-of-care failures across a multidisciplinary team round out a profile where nearly every serious claim involves a death.
Key Risks in Oncology Practice
Oncology practices face exposure related to:
Chemotherapy dosing, compounding, or administration errors
Missed or delayed cancer diagnosis or incorrect staging
Failure to inform of prognosis, risks, or treatment options
Chemotherapy extravasation and severe infusion reactions
Off-label drug use and clinical-trial adverse events
Coordination-of-care and tumor-board communication failures
HIPAA breaches of records and genomic testing data
The fatal treatment error and the wrongful-death claim are what most define the practice.
Core Coverages for Oncology Practices
A properly built oncology program typically includes:
Medical Professional Liability / Malpractice — Covers defense and damages for negligent diagnosis, treatment, or a drug error, for the entity and each oncologist, usually claims-made — so tail coverage matters at exit.
Chemotherapy & Drug-Administration Liability — Responds to dosing, compounding, and infusion errors where a small mistake can be fatal.
Clinical Trial Liability — Covers injury to patients enrolled in cancer trials the practice conducts.
General Liability — Covers non-clinical injuries, such as a patient falling in the infusion suite.
Cyber & HIPAA Liability — Pays breach response and regulatory defense for patient records and genomic data.
Regulatory & Billing E&O — Defends Medicare audits, drug-reimbursement and 340B disputes, and False Claims Act exposure.
Commercial Property & Specialty Equipment — Cover the office, infusion pumps, and temperature-sensitive drug inventory.
Workers' Compensation — Provides legally required coverage for staff, including hazardous-drug and needlestick exposure.
Umbrella / Excess Liability — Adds the high limits a wrongful-death cancer claim can demand.
What's Commonly Overlooked
Oncology programs are most often weakened by:
No tail coverage when a claims-made policy or an oncologist leaves
No distinct clinical-trial liability where the practice enrolls patients
Drug-reimbursement, 340B, and False Claims Act exposure left to a thin billing sublimit
No standalone cyber or HIPAA coverage, assumed included but not
Umbrella limits set below what a wrongful-death verdict can reach
The gap that hurts most is the claims-made tail paired with umbrella limits sized below a wrongful-death cancer claim.
Real-World Claim Examples
A chemotherapy dosing or administration error causes severe harm or death
A cancer diagnosis is missed or delayed, allowing a curable disease to progress
A patient alleges inadequate informed consent about a treatment's risks
Chemotherapy extravasation causes tissue necrosis requiring surgery
A patient enrolled in a cancer trial suffers a serious adverse event
Any one of these can be catastrophic, and a wrongful-death cancer claim can reach well into eight figures.
Regulatory & Licensing Context
Oncologists are licensed by state medical boards and typically board-certified in medical oncology, and hold DEA registration for the controlled substances and high-risk drugs they prescribe. Practices billing Medicare and Medicaid face intense scrutiny on drug reimbursement — buy-and-bill, 340B program compliance, and documentation — with False Claims Act and Stark exposure on top of ordinary coding audits. HIPAA governs patient and genomic data, OSHA and USP <800> govern hazardous-drug handling and compounding, and any clinical research adds Good Clinical Practice and IRB obligations.
Why Proper Placement Matters
Underwriters weigh the number of oncologists and their claims history, the treatment mix and acuity, chemotherapy and infusion volume as the severity driver, whether the practice compounds drugs or runs clinical trials, Medicare share, and drug-handling and dosing-verification protocols. Coverage is almost always claims-made, so the tail matters at exit, and because the severity is so high, limits and umbrella structure deserve real attention. Most business is written in the specialty healthcare market. Placing the program with a carrier that understands cancer care — and handling the tail, clinical-trial, and cyber exposures correctly — is what keeps it sound.
Our Approach
At Cory Washington & Co., we insure oncology practices around treatment-error and diagnostic risk. We structure malpractice for the entity and each oncologist with the claims-made tail handled, add drug-administration, clinical-trial, cyber, and regulatory billing coverage, and size umbrella limits to the wrongful-death severity this field carries. We also insure related practices, including hematologists, gastroenterologists, and urologists, the broader healthcare category, and medical clinics.
When a small error can be fatal, coverage has to be built for the severity — and we build it that way.
All insurance descriptions on this website are provided by Cory Washington & Co. LLC strictly for general informational purposes. They are not intended to be, and should not be relied upon as, legal, financial, or insurance advice. The information presented is general in nature and does not guarantee the availability, terms, conditions, or scope of any insurance coverage. Actual coverage is determined solely by the specific policy language issued by the insurer and remains subject to underwriting approval. Nothing on this website creates or implies an agent-client relationship, binds coverage, or alters any existing policy. Cory Washington & Co. LLC expressly disclaims any liability for actions taken, or not taken, based on the content provided here. For advice regarding your particular situation, please consult directly with a licensed insurance professional at Cory Washington & Co. LLC or another qualified insurance professional, and always review your policy documents in full.
See the coverages an oncologist business may carry — core, prevalent, and situational — plus the gap most often missed, in the Oncologist Coverage Checklist.
Complete the Oncologist Supplemental online in a few guided steps, download the fillable PDF, or browse all applications.
Frequently Asked Questions
How do I get oncologist insurance through Cory Washington & Co.?
Request a quote or contact our team. We start with a short conversation about your operations, analyze your exposures, then negotiate oncologist insurance across multiple carriers that compete for your account and present options with the trade-offs explained. Cory Washington & Co. LLC is licensed in all 50 states.
How are oncologist insurance premiums priced?
It depends on your exposure. Oncologist insurance is priced on factors like your industry, size, prior claims, and the limits and deductibles you select — so two businesses rarely pay the same. We shop your account across competing carriers and present the trade-offs in plain English.
Is oncologist insurance mandatory?
Whether oncologist insurance is strictly required depends on your state, your contracts, and your lenders or clients. Even where it is not mandatory, going without it can leave serious financial gaps. We assess your exposure and any contractual requirements, then structure coverage that meets both.
What if another agency has already declined or non-renewed my coverage?
Difficult, specialty, and previously-declined placements are a core part of our work. We access excess & surplus (E&S) and specialty markets that many generalist agencies cannot, and we explain the trade-offs clearly so you can decide with confidence.
Available in all 50 states. See how requirements differ in California, Texas, Florida, New York, or choose your state.